PLAU and in situ carcinoma: This may be an indication that uPA activity is not only involved in early events such as basement membrane degradation during transition from in situ carcinomas to invasive tumours, but also in later events of malignant progression such as invasion of tissue barriers or intravasation/extravasation of tumour cells.